Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3044290	li-solut	— (—)	10086	14465	99.99%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Mood disorders, excluding more controls

2174

5010

2.61

316.63

1.4

—

Normal-pressure hydrocephalus

494

245

26.91

307.65

1.6

1.2

—

Intracranial trauma

1314

1358

6.73

307.65

1.5

—

Malaise and fatigue

1505

2826

4.35

307.65

1.4

1.3

—

STROKE

1588

3543

3.12

307.65

1.8

1.3

—

MS-disease / Multiple Sclerosis

663

581

14.13

307.65

1.1

1.4

—

Inflammatory diseases of the central nervous system

757

675

13.90

307.65

1.8

1.3

—

Hydrocephalus

828

446

24.61

307.65

2.4

1.5

—

Neurological diseases, wide definition

927

387

12.54

307.65

1.8

1.6

—

Headache

2766

3804

5.93

307.65

1.4

1.3

—

Meningitis

391

380

12.48

307.65

1.9

1.4

—

Encephalitis

376

211

25.54

307.65

1.7

1.4

—

Cerebrovascular diseases (FINNGEN)

1226

1895

4.80

307.65

1.9

1.3

—

Viral encephalitis, not elsewhere classified/unspecified

256

131

28.46

307.65

1.6

1.5

—

Abnormal findings on diagnostic imaging of central nervous system

439

421

12.84

307.65

1.3

1.7

—

Other encephalitis

366

197

27.13

307.65

1.7

1.4

—

Demyelinating diseases of the central nervous system

795

718

13.73

307.65

1.2

1.4

—

Concussion

1099

1344

6.52

307.65

1.5

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

261

133

28.54

307.65

1.6

1.5

—

Postprocedural disorders of nervous system

526

547

11.29

307.65

1.3

1.2

—

Viral infections of the central nervous system

553

612

10.76

307.65

1.5

1.4

—

Convulsions, not elsewhere classified

880

1452

6.34

307.65

1.7

1.3

—

Other demyelinating diseases of the central nervous system

423

288

19.82

307.65

1.2

1.6

—

Disorders of optic nerve and visual pathways

534

816

7.35

307.65

1.4

1.6

—

Viral infections of the central nervous system, including avohilmo

578

654

10.44

307.65

1.5

1.4

—

Alzheimer’s disease (Early onset), excluding more controls

232

51.03

307.65

1.1

—

Delirium, not induced by alcohol and other psychoactive substances

449

673

7.12

286.79

1.3

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

711

648

5.63

274.69

1.5

—

Benign intracranial hypertension

176

45.03

271.54

1.4

1.5

—

Anxiety disorders, excluding more controls

1876

4775

2.56

271.31

1.4

—

Cerebral cysts

337

404

9.46

265.48

1.5

1.4

—

Other meningitis

199

119

23.86

250.37

2.1

1.2

—

Other mental disorders due to brain damage and dysfunction and to physical disease

431

719

6.43

249.19

1.3

1.4

—

Traumatic subdural haemorrhage

281

260

10.49

242.97

1.7

1.1

—

Other and unspecified hydrocephalus

189

116

21.76

233.23

3.0

1.3

—

Pain, not elsewhere classified

681

1827

3.85

219.19

1.4

1.3

—

Optic neuritis

273

323

9.84

218.48

1.3

1.5

—

Alzheimer’s disease (Early onset)

232

221

11.65

215.77

1.1

1.2

—

Communicating hydrocephalus

184

131

17.81

208.85

3.9

1.7

—

Cerebral palsy and other paralytic syndromes

447

916

5.25

207.10

1.8

1.6

—

Syncope and collapse

928

2541

3.12

207.04

1.5

1.3

—

Status epilepticus

215

203

12.13

202.30

1.7

1.8

—

Depression or dysthymia

1309

2700

2.70

200.28

1.5

1.4

—

Obstructive hydrocephalus

148

22.38

186.15

2.7

2.0

—

Migraine without aura

594

1672

3.69

178.85

1.4

1.6

—

Malignant neoplasm of brain, including Hilmo

262

378

7.76

176.02

2.0

1.3

—

Guillain-Barre syndrome

149

102

18.91

173.22

1.4

1.3

—

Anaemias

548

865

4.18

171.27

1.9

1.2

—

Viral meningitis, including avohilmo

237

322

8.49

169.02

1.4

—

Viral meningitis

231

306

8.75

168.51

1.4

—

Parkinson's disease, excluding more controls

215

222

9.16

168.07

1.3

1.2

—

Disorders of thyroid, IBD co-morbidities

282

257

7.68

166.50

1.5

1.3

—

Other disorders of optic [2nd] nerve and visual pathways

299

533

6.19

162.92

1.6

1.7

—

Malignant neoplasm of brain

209

260

9.21

160.27

2.0

1.3

—

Motor neuron disease ALS

40.09

160.20

1.1

1.2

—

Recurrent or chronic depression

839

2059

2.89

156.16

1.3

1.4

—

Motor neuron disease (with DMD)

100

35.29

156.11

1.1

1.8

—

Papilloedema, unspecified

172

174

11.90

155.67

1.5

1.4

—

Parkinson's disease, strict definition, excluding more controls

193

203

9.11

151.38

1.4

1.2

—

Malignant neoplasm of eye, brain and central nervous system

226

336

7.51

147.71

2.0

1.4

—

Hydrocephalus in other diseases

46.62

145.49

3.5

1.4

—

Depression medications

624

939

3.42

136.33

1.5

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

637

2198

2.94

133.14

1.3

1.4

—

Tick-borne viral encephalitis, including avohilmo

38.33

132.53

1.1

1.3

—

Benign neoplasm of meninges

338

804

4.47

130.15

1.6

1.3

—

Non-invasive ventilation

585

1689

3.07

128.01

1.6

1.4

—

Memory loss

271

546

5.27

127.78

1.3

—

Benign neoplasm: Cerebral meninges

317

733

4.61

126.75

1.5

1.3

—

Tick-borne viral encephalitis

42.84

119.64

1.1

1.3

—

Paralytic strabismus

254

525

5.20

116.79

1.5

—

Other disorders of fluid, electrolyte and acid-base balance

669

2408

2.68

116.62

1.6

1.4

—

Substance abuse, excluding more controls

1022

3907

2.22

116.02

1.4

—

General examination and investigation of persons without complaint and reported diagnosis

1212

2948

2.17

115.40

1.4

1.3

—

Cardiovascular diseases (excluding rheumatic etc)

1370

3912

2.04

113.95

1.6

1.4

—

Cardiovascular diseases

1308

3401

2.07

112.07

1.6

1.5

—

Viral hepatitis, IBD co-morbidity

116

103

11.71

111.86

1.8

1.2

—

Migraine without aura and triptan purchases

486

1620

3.12

111.76

1.3

1.4

—

Any reimbursement code in KELA

1201

2848

2.15

110.62

1.7

1.3

—

Other and unspecified degenerative diseases of nervous system

133

150

9.96

109.85

1.3

1.2

—

Bacterial meningitis

170

261

7.30

108.05

2.0

1.4

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

137

102

10.30

104.32

1.2

1.1

—

Oedema, not elsewhere classified

563

2064

2.72

102.24

1.3

—

Migraine with aura and triptan purchases

457

1551

3.06

101.84

1.3

1.4

—

Personality disorders, excluding more controls

549

2065

2.72

99.68

1.3

1.4

—

Hypo-osmolality and hyponatraemia

398

1252

3.26

99.15

1.6

1.4

—

Meningitis, viral

36.18

98.34

1.5

1.4

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1177

2948

2.05

97.00

1.5

1.3

—

Other disorders of central nervous system

15.07

96.76

1.6

1.3

—

Secondary parkinsonism, excluding more controls

20.82

96.35

1.2

1.4

—

Nonorganic sleeping disorders, excluding more controls

462

1625

2.92

95.99

1.3

1.4

—

Dementia in Alzheimer disease

313

707

3.79

94.91

1.2

1.3

—

Circumscribed brain atrophy

111

120

10.49

94.84

1.1

1.3

—

Use of teriflunomide

13.91

90.97

1.1

1.3

—

Traumatic subarachnoid haemorrhage

13.25

90.25

1.6

1.3

—

Other and unspecified visual disturbances

305

879

3.64

89.37

1.3

1.4

—

Hypothyroidism (congenital or acquired)

469

883

3.03

89.21

1.4

1.2

—

Hemiplegia

181

354

5.48

88.72

1.6

1.4

—

Schizophrenia or delusion, excluding more controls

575

2313

2.51

88.67

1.2

1.4

—

Hypothyroidism and >3 levothyroxin purchases

467

882

3.02

88.56

1.4

1.2

—

Hypothyroidism, levothyroxine purchases

467

882

3.02

88.56

1.4

1.2

—

Enlarged lymph nodes

316

952

3.41

85.64

1.5

1.3

—

Systemic atrophies primarily affecting the central nervous system

160

295

5.89

84.00

1.6

1.5

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

136

133

7.31

78.43

1.3

1.6

—

Acute lymphocytic leukaemia

16.50

75.93

12.3

1.4

—

Acute lymphocytic leukaemia, including Hilmo

16.50

75.93

12.3

1.4

—

Acute lymphocytic leukaemia, helper endpoint

16.50

75.93

12.3

1.4

—

Invasive ventilation

225

593

4.01

75.54

2.1

1.7

—

Other general symptoms and signs

144

268

5.59

73.17

1.8

1.7

—

Hypertensive diseases (excluding secondary)

980

3000

1.93

70.78

1.4

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

171

383

4.66

70.73

1.4

1.2

—

Pure hypercholesterolaemia

1290

4734

1.75

70.13

1.3

1.4

—

Other diseases of spinal cord

111

171

7.05

69.90

2.4

1.2

—

Brain meningioma, including Hilmo

171

390

4.68

69.87

1.9

1.3

—

Brain meningioma

167

380

4.69

68.46

1.8

1.3

—

Other lack of coordination

9.95

68.44

1.3

1.5

—

Paraplegia, diplegia of upper limbs

103

153

7.52

67.57

1.8

1.5

—

352

1302

2.79

66.98

1.7

1.4

—

Third [oculomotor] nerve palsy

117

8.57

65.13

1.3

1.4

—

Small fibre neuropathy

119

219

5.94

62.85

1.3

—

Antihypertensive medication - note that there are other indications

1190

3584

1.76

62.62

1.5

—

Brain glioblastoma and astrocytoma

126

8.03

62.37

1.8

1.1

—

Speech and linguistic disorders, excluding more controls

217

589

3.59

62.08

2.0

2.1

—

Somnolence, stupor and coma

122

231

5.58

61.85

1.6

—

Diarrhoea and gastroenteritis of presumed infectious origin

1302

7091

1.66

61.73

1.4

—

Sixth [abducent] nerve palsy

122

243

5.43

58.91

1.5

1.6

—

Complications of other internal prosthetic devices, implants and grafts

132

281

5.00

58.70

3.2

1.4

—

Non-Hodgkin lymphoma, all

127

264

5.09

57.97

1.7

1.2

—

Rare circulating lymphoid malignancy, including Hilmo

113

216

5.68

57.18

9.9

1.2

—

Benign neoplasm of brain and other parts of central nervous system

187

528

3.73

56.91

2.0

1.5

—

Follow-up examination after treatment for conditions other than malignant neoplasms

729

2520

1.95

56.59

1.3

—

Narcolepsy and cataplexy

19.75

55.15

1.2

1.8

—

Other acute disseminated demyelination

10.04

54.09

1.2

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1791

7677

1.51

53.89

1.4

—

Focal brain injury

141

6.47

53.82

1.9

1.2

—

Cluster headache, strict

108

213

5.37

52.43

1.3

—

Other CVD (FINNGEN)

243

618

3.09

52.24

1.5

1.2

—

Ocular pain

230

778

3.08

52.02

1.4

1.6

—

Hypothyroidism, drug reimbursement

241

551

3.11

51.77

1.4

1.1

—

Symptoms and signs concerning food and fluid intake

192

587

3.35

50.87

1.7

1.4

—

Post-traumatic stress disorder

221

748

3.06

49.79

1.3

1.4

—

Cluster headache, wide

111

235

4.98

49.61

1.3

—

Use of peginterferon beta-1a

18.45

48.96

1.1

1.2

—

Urinary track infection

1043

3110

1.70

48.64

1.4

—

Dementia in other diseases classified elsewhere

113

247

4.80

48.51

1.2

—

Progressive vascular leukoencephalopathy

185

5.45

47.75

1.1

1.2

—

Endovascular or surgical operations to intracerebral aneurysms

149

411

3.79

46.87

1.8

1.2

—

Fungal Sepsis

116

269

4.54

46.37

1.6

1.2

—

Hyperkinetic disorders, excluding more controls

276

1010

2.61

46.02

1.4

1.8

—

Fibromyalgia

217

766

2.93

45.34

1.2

1.4

—

Any operation in hilmo

27.02

45.23

1.4

1.0

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

153

447

3.61

44.35

1.5

1.4

—

Dissociative [conversion] disorders

118

291

4.28

43.60

1.2

1.7

—

Brain glioblastoma

7.74

43.29

1.7

1.1

—

Alcohol abuse, main dg, excluding more controls

263

1054

2.55

42.57

1.3

1.4

—

Generalized anxiety disorder

347

1570

2.26

42.53

1.2

1.4

—

Gastrointestinal diseases

1043

3231

1.63

42.18

1.7

1.4

—

Implicit fungal Sepsis

107

253

4.46

41.77

1.6

1.2

—

Lymphoid leukaemia

142

411

3.62

41.68

8.3

1.3

—

Other and unspecified nonorganic psychotic disorders

404

1972

2.09

40.98

1.2

1.4

—

Brain glioblastoma, helper endpoint

7.26

40.87

1.7

1.2

—

Optic atrophy

127

6.22

39.92

2.0

1.9

—

Optic atrophy, wide definition

130

6.05

38.91

2.0

1.9

—

Factors influencing health status and contact with health services

439

1068

2.09

38.46

1.5

1.2

—

Abnormal findings in cerebrospinal fluid

19.02

38.23

1.8

1.6

—

Other heart diseases

789

3075

1.69

38.13

1.5

—

Diffuse brain injury

7.30

37.85

1.8

1.3

—

Psychotic depression

116

312

3.83

37.71

1.3

1.5

—

Encephalopathy

9.33

37.67

1.6

1.7

—

Other necrotizing vasculopathies (FG)

138

418

3.43

37.67

1.3

—

Gastro-oesophageal reflux disease

1139

6384

1.52

37.25

1.3

1.4

—

Speech and linguistic disorders

227

872

2.58

36.79

2.0

2.1

—

Other disorders of nervous system

143

450

3.29

36.66

1.8

1.2

—

Use of galantamine

142

447

3.27

36.25

1.2

—

Other symptoms and signs involving general sensations and perceptions

220

4.40

36.19

1.2

1.6

—

Other disorders of binocular movement

174

5.01

35.92

1.6

1.7

—

Other and unspecified paralytic syndromes

6.90

33.96

1.3

1.2

—

Hypokalaemia

217

888

2.50

33.77

2.0

1.3

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

339

1674

2.07

33.48

1.2

1.4

—

Hypopituitarism

184

702

2.72

33.40

1.6

2.2

—

Vascular dementia

132

400

3.24

33.36

1.3

—

Other/unspecified cytomegaloviral diseases

139

5.37

33.05

2.5

1.4

—

Specific development disorders of speech and language

162

560

2.90

32.91

1.9

2.5

—

Panhypopituitarism

113

5.83

32.04

2.0

1.6

—

Monoplegia

110

5.96

31.96

1.3

1.4

—

Use of glatiramer acetate

136

5.38

31.92

1.1

1.7

—

Diabetes insipidus

7.82

31.76

2.0

1.2

—

Other necrotizing vasculopathies

155

556

2.89

31.68

1.3

—

Visual impairment including blindness (binocular or monocular)

137

459

3.08

31.57

1.7

1.5

—

Emotionally unstable personality disorder

267

1241

2.20

31.02

1.2

1.4

—

Nystagmus and other irregular eye movements

110

5.88

30.90

1.8

2.4

—

Special screening examination for infectious and parasitic diseases

407

1573

1.91

30.68

1.4

1.3

—

Cytomegalovirus infection, IBD co-morbidity

160

4.81

30.65

2.4

1.3

—

Secondary parkinsonism+Parkinsonism in other disease

172

4.60

30.57

1.2

—

Other and unspecified mood [affective] disorders

158

583

2.79

30.54

1.5

—

Disorders of psychological development

272

1182

2.19

30.51

1.9

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

441

2126

1.84

30.25

1.7

—

Panic disorder

286

1379

2.11

30.12

1.2

1.4

—

Cytomegaloviral disease

163

4.71

29.93

2.4

1.3

—

Secondary parkinsonism

172

4.54

29.68

1.2

—

Disorders of speech understanding and production

126

412

3.14

29.45

1.9

2.9

—

Other intracranial haemorrhages

161

4.61

29.26

2.2

1.2

—

Vocal cord dysfunction

229

891

2.30

29.15

1.4

—

Trigeminal neuralgia

132

455

3.00

29.06

1.3

1.4

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

100

293

3.57

28.95

1.6

1.3

—

Persons encountering health services for specific procedures, not carried out

183

746

2.52

28.91

1.3

1.5

—

Cytomegaloviral disease, including avohilmo

168

4.56

28.82

2.4

1.6

—

Other degenerative diseases of the basal ganglia

125

5.26

28.68

1.3

1.2

—

Other problems related to primary support group, including family circumstances

247

1117

2.20

28.59

4.1

1.5

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

183

758

2.48

27.95

1.3

1.4

—

Neuralgia and neuritis, unspecified

117

390

3.11

27.36

1.7

1.4

—

Intracranial and intraspinal abscess and granuloma

6.87

27.05

3.0

1.3

—

Brachial plexus disorders

189

807

2.40

26.99

1.2

1.4

—

Cluster headache, strict, including avohilmo

123

426

3.00

26.96

1.3

1.4

—

Leukaemia of unspecified cell type

7.64

26.87

7.8

1.4

—

Phobic anxiety disorders

256

1235

2.11

26.80

1.5

—

Cramp and spasm

119

407

3.05

26.71

1.6

1.5

—

Inflammatory diseases of female pelvic organs

1022

4846

1.46

26.44

1.3

1.4

—

Retrobulbar neuritis in diseases classified elsewhere

12.71

26.21

1.1

1.6

—

Dementia due to Parkinsons disease, excluding more controls

9.15

26.06

1.4

1.2

—

Benign neoplasm: Brain, supratentorial

116

5.21

26.04

2.3

1.7

—

Cluster headache, wide,, including avohilmo

126

453

2.89

25.79

1.3

1.4

—

Immunodeficiency with predominantly antibody defects

200

3.97

25.12

2.4

1.7

—

Cardiac arrhythmias

921

4042

1.47

25.04

1.3

1.4

—

Alzheimer’s disease (Atypical or mixed)

141

537

2.64

24.80

1.2

1.3

—

Emotional disorders starting during childhood or adolecense, excluding more controls

103

326

3.16

24.74

3.1

2.3

—

Nonpyogenic thrombosis of intracranial venous system

7.02

24.41

1.7

1.3

—

Functional dyspepsia

440

2607

1.71

24.34

1.4

—

Giant cell arteritis with polymyalgia rheumatica

244

3.55

23.97

1.2

—

Temporal arteritis

244

3.55

23.97

1.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

662

2691

1.56

23.88

1.4

1.3

—

Vascular dementia (subcortical)

134

4.46

23.31

1.2

—

Thiamine deficiency

9.25

23.22

1.1

1.4

—

Frontotemporal dementia, wide, incl. Pick's disease

9.09

23.14

1.1

1.2

—

Social phobias

168

729

2.36

23.13

1.5

1.6

—

Giant cell arteritis

290

3.26

23.09

1.2

—

Rheumatism, unspecified

222

1081

2.09

22.93

1.3

1.4

—

Volume depletion

150

624

2.45

22.68

1.4

1.5

—

Mental and behavioural disorders due to opioids

337

3.06

22.49

1.8

1.5

—

Vitamin deficiency

107

381

2.91

22.34

1.2

1.6

—

Vitamin deficiency, wide

107

381

2.91

22.34

1.2

1.6

—

Adrenocortical insufficiency

281

3.27

22.31

1.4

1.6

—

Irregular menses

806

4162

1.47

22.22

1.4

1.3

—

Other metabolic disorders

232

1163

2.03

22.15

1.6

1.4

—

Congenital malformations of the nervous system

211

3.67

21.84

1.9

3.5

—

Thrombocytopenia, unspecified

141

583

2.49

21.77

2.9

1.4

—

Pain and other conditions associated with female genital organs and menstrual cycle

377

1835

1.74

21.68

1.3

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

149

638

2.40

21.31

1.8

1.5

—

Disturbance of activity and attention

270

1412

1.90

21.13

1.4

1.8

—

Other and unspecified drugs and medicaments

166

750

2.27

20.92

1.3

1.5

—

Other infectious diseases

137

570

2.46

20.85

1.5

1.4

—

Inflammatory disease of uterus

255

1350

1.92

20.81

1.2

1.3

—

Frontotemporal dementia

8.98

20.51

1.1

1.3

—

Fasciculation

5.52

20.43

1.2

1.3

—

Drug-induced neutropenia

142

608

2.40

20.36

2.0

1.4

—

Lesion of lateral popliteal nerve

101

371

2.81

19.93

1.3

1.4

—

Autonomic disorders

143

4.09

19.89

1.4

1.2

—

Somnolence

5.35

19.85

1.9

2.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

177

838

2.16

19.84

2.1

1.4

—

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

4.90

19.72

1.3

1.2

—

Sequelae of injuries of head

112

437

2.64

19.63

1.8

1.4

—

Disorders of optic nerve, not elsewhere classified

132

4.23

19.54

1.3

1.2

—

Malignant immunoproliferative diseases

6.36

19.53

1.4

1.3

—

Disorders of brain, other and unspecified

6.64

19.25

1.5

1.3

—

Other and unspecified tonsillitis

558

3071

1.52

18.94

1.4

—

Chorioretinal inflammation

221

3.36

18.85

1.4

—

KRA_PSY_EATING, excluding more controls

142

621

2.31

18.82

1.2

1.5

—

Hyperkinetic disorders

281

1543

1.81

18.78

1.4

1.9

—

Dystonia

111

445

2.57

18.43

1.3

1.5

—

Brain astrocytoma

8.38

18.36

2.0

1.2

—

Brain astrocytoma, including Hilmo

8.38

18.36

2.0

1.2

—

Enterocolitis due to Clostridium difficile

169

810

2.12

18.32

2.0

1.5

—

SLE (Finngen)

230

3.24

18.26

1.3

1.8

—

Cauda equina syndrome

4.78

17.85

1.3

1.2

—

Continuous positive airway pressure

255

1171

1.83

17.73

1.6

—

Infections with a predominantly sexual mode of transmission

510

3378

1.52

17.66

1.5

1.3

—

Other disorders of adrenal gland

379

2.67

17.57

1.4

1.7

—

Tetraplegia

6.96

17.45

5.2

3.2

—

Other congenital malformations of circulatory system

202

3.37

17.36

2.6

1.4

—

Unspecified/other endometriosis

174

844

2.06

17.28

1.3

—

Pneumocystosis

122

4.15

17.27

1.8

1.2

—

Pneumocystosis, including avohilmo

122

4.15

17.27

1.8

1.2

—

Other/unspecified disorders of vestibular function

298

2.88

17.17

1.2

1.4

—

Other disorders of peripheral nervous system

7.10

17.03

1.2

1.3

—

Postviral fatigue syndrome

5.87

16.99

1.2

1.9

—

Post-traumatic hydrocephalus, unspecified

20.42

16.83

2.0

1.2

—

Varicella [chickenpox], including avohilmo

111

466

2.45

16.70

2.1

2.3

—

Other disorders of optic disc

104

4.40

16.59

1.4

1.2

—

Benign neoplasm: Brain, infratentorial

6.67

16.49

2.3

—

Myasthenia gravis

113

4.21

16.48

1.6

1.3

—

Viral infections of central nervous system, not elsewhere classified/unspecified

5.08

16.43

1.4

1.3

—

Varicella [chickenpox]

386

2.59

16.42

1.8

1.9

—

Cerebral arteritis

27.71

16.41

2.5

1.1

—

Assault

241

1354

1.81

16.39

1.3

1.5

—

Protozoal diseases, including avohilmo

225

3.14

16.34

1.6

1.3

—

Symptoms and signs involving appearance and behaviour

6.59

16.19

1.9

1.4

—

Brain astrocytoma, helper endpoint

7.15

16.00

2.0

1.5

—

Myeloid leukaemia

167

3.49

15.93

2.8

1.2

—

Protozoal diseases

218

3.15

15.93

1.6

1.3

—

Other facial nerve disorders

203

3.22

15.83

1.2

1.4

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

200

1073

1.89

15.79

1.6

1.3

—

Other or unspecified paralytic strabismus

6.75

15.78

1.9

1.5

—

Arnold-Chiari syndrome

5.06

15.77

1.7

2.4

—

Disorders of mineral metabolism

139

657

2.16

15.73

1.4

1.5

—

Mixed and other personality disorders

150

736

2.08

15.44

1.3

1.4

—

Lack of expected normal physiological development

4.27

15.38

2.5

2.1

—

Other and unspecified immunodeficiencies with predominantly antibody defects

4.56

15.30

3.3

1.5

—

Vertigo of central origin

4.41

15.26

1.2

—

Assault by bodily force

151

746

2.07

15.26

1.2

1.6

—

Other disorders of glucose regulation and pancreatic internal secretion

148

727

2.08

15.17

1.6

1.8

—

Other and unspecified disorders of binocular movement

6.57

15.17

2.2

2.7

—

Mental and behavioural disorders due to sedatives or hypnotics

130

609

2.19

15.13

1.2

1.5

—

Hyperhidrosis

148

3.53

15.05

1.1

1.6

—

Failure and rejection of transplanted organs and tissues

4.29

14.99

3.5

1.4

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

326

2.65

14.97

1.4

1.2

—

Polycystic ovarian syndrome, consortium definition

1083

4755

1.31

14.95

1.4

1.3

—

Paracetamol or NSAID medication

229

630

1.85

14.83

1.9

2.0

—

Faecal incontinence

139

676

2.09

14.62

1.8

1.4

—

Other congenital malformations of nervous system

4.70

14.57

1.7

2.7

—

Decubitus ulcer and pressure area

396

2.45

14.53

2.0

1.4

—

Hypermetropia

140

685

2.09

14.52

1.8

2.1

—

Amenorrhoea

131

628

2.13

14.36

1.3

—

Cerebral amyloid angiopathy

12.90

14.28

1.3

1.2

—

Hypoglycaemia, other or unspecified

124

585

2.17

14.20

1.7

1.9

—

Early lumbar disc prolapse, operated

160

829

1.96

14.10

1.3

1.4

—

Mental disorders, not otherwise specified

154

789

1.99

14.09

1.2

1.5

—

Maternal care for other conditions predominantly related to pregnancy

343

2142

1.58

14.09

1.3

—

Heterophoria

145

729

2.03

13.99

1.6

1.9

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

313

1336

1.63

13.98

1.4

1.2

—

Other obstetric conditions, not elsewhere classified

530

2317

1.46

13.90

1.3

—

Other specified/unspecified necrotizing vasculopathies

4.37

13.90

1.8

1.2

—

Internuclear ophthalmoplegia

16.07

13.80

1.4

—

Lagophthalmos

4.65

13.77

1.7

1.2

—

Atypical facial pain

396

2.41

13.65

1.2

1.4

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

518

2260

1.46

13.61

1.3

—

Hypermobility syndrome

107

486

2.26

13.53

1.3

1.6

—

Immunodeficiencies

418

2.36

13.45

2.2

2.0

—

Use of fingolimod

4.83

13.35

1.2

1.8

—

Need for other prophylactic measures

111

517

2.20

13.21

2.6

1.7

—

Asthma and allergy, excluding more controls

196

1091

1.79

13.19

1.3

—

Systemic lupus erythematosus

277

2.68

13.16

1.3

1.5

—

Acute and transient psychotic disorders

191

1072

1.81

13.16

1.3

1.4

—

Amblyopia ex anopsia

349

2.48

13.07

1.6

2.4

—

Acute pharyngitis

253

1522

1.67

13.01

1.7

1.4

—

Asthma and allergy

195

1089

1.79

12.97

1.3

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

5.49

12.93

2.3

1.1

—

Secondary hypertension

116

544

2.13

12.91

1.4

—

Abnormal blood-pressure reading, without diagnosis

388

2.38

12.88

1.3

1.6

—

Kela reimbursement Agammaglobulinemia (D80-84)

5.26

12.87

3.5

1.7

—

Sleep disorders, other/unspecified

292

2.61

12.84

1.2

1.6

—

Intermittent heterotropia

118

569

2.12

12.78

1.6

2.4

—

Manic episode

202

2.96

12.78

1.1

1.4

—

Paroxysmal tachycardia

309

1635

1.58

12.71

1.4

—

Endometriosis

497

2011

1.45

12.58

1.3

—

Chronic gastritis

337

2208

1.54

12.57

1.2

1.3

—

183

3.06

12.53

1.4

1.5

—

Convergent concomitant strabismus

109

515

2.17

12.51

1.5

2.0

—

6-mercaptopurine

279

2.62

12.42

10.5

1.5

—

Behavioural disorders, excluding more controls

142

3.35

12.40

1.3

2.1

—

Emotional disorders and disorders of social functioning with onset specific to childhood

110

512

2.15

12.39

2.9

2.4

—

Unspecified privation

166

910

1.85

12.38

1.4

—

Other viral hepatitis, including avohilmo

123

611

2.06

12.36

1.7

1.5

—

Implicit parasitic Sepsis, including avohilmo

10.16

12.33

1.3

1.4

—

Benign neoplasm: Spinal cord

100

3.90

12.31

1.9

1.2

—

Obsessive-compulsive disorder

117

571

2.09

12.27

1.3

1.6

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

122

606

2.06

12.26

1.3

1.6

—

Other disorders starting during childhood or adolecense, excluding more controls

336

2.41

12.16

3.4

2.6

—

Unknown and unspecified causes of morbidity

347

2.40

12.16

1.3

1.4

—

Anankastic personality disorder

343

2.43

12.13

1.6

1.5

—

Corticotropin deficiency

4.99

12.12

2.0

1.5

—

Statin medication

994

4360

1.29

12.08

1.4

—

Drug-induced adrenocortical insufficiency

141

3.34

11.97

1.3

—

Other and unspecified spinal muscular atrophies

5.24

11.89

1.4

1.2

—

Ovarian cyst

510

2065

1.42

11.76

1.3

—

Beningn neoplasm: Meninges, unspecified

108

3.69

11.76

2.1

1.3

—

All chronic kidney diseases

729

4396

1.33

11.69

1.4

1.5

—

Degeneration of the brain due to alcohol

143

3.27

11.67

1.2

1.3

—

Intentional self-harm by unspecified means

3.96

11.64

1.4

1.3

—

Disorders of acoustic nerve

208

2.84

11.61

1.7

1.2

—

Agoraphobia

242

2.68

11.57

1.3

1.5

—

SLE, ICD10

266

2.60

11.55

1.3

1.5

—

SLE, strict definition

266

2.60

11.55

1.3

1.5

—

Viral hepatitis, including avohilmo

136

717

1.93

11.54

1.7

1.5

—

Nonhereditary hypogammaglobulinemia

4.35

11.53

1.5

1.4

—

Fourth [trochlear] nerve palsy

155

3.15

11.47

1.8

1.2

—

Other viral hepatitis

115

574

2.05

11.45

1.8

1.4

—

Hypersomnia

3.83

11.41

1.2

—

Insulin medication

844

5430

1.30

11.35

1.5

1.4

—

Emotional disorders starting during childhood or adolescence

104

497

2.12

11.34

3.0

2.2

—

Generalized epilepsy

350

2.35

11.14

1.5

2.0

—

Attention to artificial openings

277

2.51

11.07

3.5

1.7

—

Sequelae of other external causes

100

480

2.13

11.07

1.4

—

Postzoster neuralgia

3.72

11.05

1.3

1.2

—

Use of dimethyl fumarate

4.48

11.05

1.0

1.2

—

Lesion of radial nerve

278

2.51

11.01

1.1

1.4

—

Tubulo-interstitial nephritis, not specified as acute or chronic

101

488

2.11

10.94

1.4

—

Other cranial nerve disorders in other disorders

14.42

10.88

1.6

1.3

—

Disorders of calcium metabolism

100

484

2.11

10.81

1.4

1.5

—

Hereditary ataxia

3.91

10.75

1.2

2.0

—

Unspecified visual impairment (binocular)

100

3.65

10.75

1.2

1.7

—

Viral hepatitis

127

673

1.92

10.65

1.8

1.5

—

Epidural haemorrhage

9.58

10.64

3.2

1.6

—

Degeneration of nervous system due to alcohol

152

3.07

10.57

1.2

1.3

—

Other specified and unspecified disorders of eye and adnexa

260

2.52

10.51

1.4

—

Other and unspecified erythematous conditions

237

2.61

10.47

1.3

1.8

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

287

1898

1.53

10.41

1.2

1.3

—

Algoneurodystrophy

262

2.51

10.38

1.2

1.5

—

Unspecified misadventure during surgical and medical care

466

2.11

10.35

1.6

1.4

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

111

568

1.99

10.30

1.2

1.4

—

Symptoms and signs involving emotional state

187

2.80

10.28

1.2

2.2

—

Other specified and unspecified personality disorders

148

833

1.81

10.24

1.3

1.5

—

Drug-induced polyneuropathy

4.31

10.18

13.6

1.9

—

Excessive vomiting in pregnancy

141

784

1.83

10.17

1.3

—

Hyperosmolality and hypernatraemia

3.91

10.17

1.3

1.4

—

Other gastritis (incl. Duodenitis)

284

1885

1.52

10.11

1.4

—

Impotence

379

2.21

10.01

1.5

1.4

—

Schizoaffective disorder

130

709

1.87

10.00

1.2

1.5

—

Cerebral oedema

18.18

9.99

2.9

1.9

—

Use of riluzole

9.43

9.93

1.0

1.3

—

Acute myeloid leukaemia

3.93

9.91

2.7

1.2

—

Acute myeloid leukaemia, helper endpoint

3.93

9.91

2.7

1.2

—

Acute myeloid leukaemia, including Hilmo

3.93

9.91

2.7

1.2

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

256

2.50

9.90

1.5

1.7

—

Transient global amnesia

116

611

1.93

9.90

1.2

1.4

—

Other drug-induced secondary parkinsonism

4.40

9.80

1.2

1.3

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

9.24

9.78

1.4

2.8

—

Polyarteritis nodosa and related conditions

3.63

9.77

1.5

—

Vertical strabismus

270

2.44

9.74

2.1

1.7

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

5.07

9.70

1.5

1.1

—

Atypical virus infections of central nervous system, including avohilmo

4.23

9.68

1.5

1.2

—

Benign neoplasm: Spinal meninges

4.21

9.66

2.2

1.1

—

Acute myeloid leukaemia and myelodysplastic syndromes

149

2.97

9.65

2.2

1.1

—

Chondrocostal junction syndrome [Tietze]

290

2.37

9.62

1.2

1.6

—

Viral and other specified intestinal infections, including avohilmo

420

2913

1.40

9.60

1.6

1.5

—

Vascular dementia (undefined)

132

3.04

9.50

1.3

1.2

—

Osteoporosis with pathological fracture (FG)

462

2.04

9.41

1.5

1.4

—

Other erythematous conditions

269

2.40

9.35

1.3

1.8

—

Endometriosis of pelvic peritoneum

240

1419

1.55

9.33

1.3

—

Spasmodic torticollis

251

2.46

9.33

1.2

1.5

—

Implicit parasitic Sepsis

9.05

9.32

1.4

1.3

—

Amyloidosis

147

2.95

9.28

1.3

—

Other coagulation defects

119

647

1.87

9.27

1.7

1.5

—

Vascular syndromes of brain in cerebrovascular disorders

239

2.47

9.26

1.5

1.3

—

Use of amantadine

116

3.23

9.20

1.1

1.2

—

Unspecified urinary incontinence

128

713

1.82

9.20

1.4

—

Convergence insufficiency and excess

101

3.41

9.18

1.3

1.4

—

Benign neoplasm: Cranial nerves

223

2.54

9.16

1.7

1.2

—

Chronic viral hepatitis

482

2.01

9.14

1.9

1.5

—

Otalgia

139

796

1.77

9.12

1.9

1.8

—

Causalgia

112

3.25

9.05

1.3

1.6

—

Pneumonia due to other infectious organisms, not elsewhere classified

230

2.50

9.05

1.7

1.4

—

Neuromyelitis optica

9.66

9.04

1.2

1.3

—

Maltreatment syndromes

477

2.01

9.03

1.2

1.6

—

Atypical virus infections of central nervous system

4.13

9.03

1.5

1.2

—

Event of undetermined intent

112

603

1.89

9.03

1.6

1.5

—

Excessive, frequent and irregular menstruation

542

2165

1.34

8.94

1.5

1.3

—

Syphilis

208

2.58

8.92

1.6

1.3

—

Syphilis, including avohilmo

208

2.58

8.92

1.6

1.3

—

Other neurotic disorders

326

2.22

8.87

1.3

1.4

—

Other and unspecified syphilis, including avohilmo

9.94

8.81

1.1

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

130

3.04

8.80

4.8

2.9

—

Acute suppurative otitis media

412

2801

1.38

8.79

2.1

1.4

—

Childhood asthma (age<16)

185

892

1.63

8.77

1.4

—

Metabolic disorder, other/unspecified

9.07

8.77

1.3

5.0

—

Anomalies of pupillary function

158

2.81

8.73

1.1

1.5

—

Acute mastoiditis

4.25

8.66

1.2

1.6

—

Abnormal reflex

7.30

8.62

1.3

—

Systemic lupus erythematosus, unspecified

236

2.44

8.61

1.3

1.4

—

Childhood asthma (age<16), excluding more controls

184

891

1.63

8.58

1.4

—

Other specified disorders of muscle

177

2.66

8.51

1.1

1.4

—

Inflammatory diseases of prostate (prostatitis)

156

940

1.68

8.49

1.5

1.4

—

Other female pelvic inflammatory diseases

221

1448

1.54

8.49

1.3

—

Acute lymphadenitis

495

1.95

8.48

1.9

1.6

—

Other peripheral vertigo

127

729

1.77

8.30

1.3

—

Osteonecrosis

514

1.92

8.25

1.9

1.4

—

Other maternal disorders predominantly related to pregnancy

805

4029

1.26

8.24

1.3

1.4

—

Other specified/unspecified dorsopathies

243

2.36

8.05

1.3

1.6

—

Collagenous colitis

137

811

1.71

8.04

1.4

—

Malnutrition

148

2.79

8.03

2.2

2.5

—

Hyperfunction of pituitary gland

408

2.02

8.00

1.4

1.7

—

Amyloidosis, other/unspecified

121

2.99

7.96

1.3

1.2

—

Neuralgic amyotrophy

11.89

7.92

1.1

—

Drug-induced headache, not elsewhere classified

6.37

7.90

1.6

1.1

—

Other eating disorders

451

1.96

7.89

1.3

1.9

—

Ulcer of vagina/vulva

227

2.40

7.88

1.1

1.6

—

Scleritis and episcleritis

537

1.88

7.85

1.1

1.4

—

Superficial injury of forearm

161

1000

1.63

7.85

1.3

1.7

—

Astigmatism

107

594

1.83

7.84

2.4

2.1

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

101

3.20

7.83

1.3

1.6

—

Iridocyclitis in diseases classified elsewhere

139

2.83

7.82

1.5

1.7

—

Patent foramen ovale

210

2.47

7.81

1.2

3.1

—

Toxic effect of other and unspecified substances

3.31

7.78

1.5

—

Acute generalized exanthematous pustulosis

358

2.08

7.78

1.8

1.7

—

Other and unspecified mononeuropathies, also in other diseases

204

2.46

7.75

1.3

1.5

—

Sequelae of infectious and parasitic diseases, including avohilmo

102

561

1.84

7.72

1.7

1.4

—

Behavioural disorders

187

2.54

7.68

1.3

1.9

—

Menorrhagia

457

1908

1.34

7.66

1.4

1.3

—

Hypogonadotropic hypogonadism

249

2.31

7.65

1.3

1.5

—

Haemophagocytic lymphohistiocytosis

19.51

7.62

1.4

—

Explicit fungal Sepsis

6.82

7.55

1.9

1.4

—

Haemorrhage, not elsewhere classified

165

2.58

7.46

2.2

1.2

—

Myositis

172

2.56

7.41

1.4

1.3

—

Explicit fungal Sepsis, including avohilmo

6.57

7.38

1.9

1.4

—

Other and unspecified disorders of autonomic nervous system

4.88

7.37

1.2

1.3

—

Disorders of pituitary gland, other and/or unspecified

4.58

7.36

1.4

1.3

—

Complications of genitourinary prosthetic devices, implants and grafts

173

2.55

7.33

1.4

—

Other and unspecified syphilis

9.79

7.29

1.1

—

Redundant prepuce, phimosis and paraphimosis

261

1795

1.44

7.28

1.3

1.5

—

Injury of nerves and spinal cord at neck level

162

2.61

7.27

1.5

1.3

—

Hypercalcemia

354

2.05

7.27

1.2

1.4

—

Dermatitis due to substances taken internally

451

1.92

7.25

1.7

1.6

—

Occlusion and stenosis of arteries, not leading to stroke

4.03

7.21

1.6

1.4

—

Mononeuritis multiplex

8.55

7.20

1.7

1.3

—

Conduct disorder

187

2.48

7.19

1.3

2.0

—

Atrial fibrillation and flutter

360

1700

1.37

7.19

1.3

—

Extracorporeal dialysis

474

1.89

7.17

1.5

—

Senile degeneration of the brain, not elsewhere classified

10.74

7.17

1.7

1.2

—

Myocarditis

315

2.09

7.13

1.6

1.3

—

Other disorders of white blood cells

440

1.92

7.11

2.8

1.5

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

200

2.40

7.10

1.3

1.4

—

Burns classified according to extent of body surface involved

3.64

7.10

1.4

1.2

—

Other disorders of penis

129

777

1.68

7.10

1.4

1.9

—

Viral pneumonia (unknown virus, not influenza)

105

599

1.78

7.10

1.4

1.5

—

Other/unspecified reactive arthropathies

101

570

1.80

7.09

1.2

1.4

—

Early lumbar disc prolapse operation

165

1058

1.58

7.09

1.3

1.4

—

Moderate visual impairment, binocular

170

2.52

7.06

1.7

1.4

—

Sequelae of injuries of neck and trunk

226

2.31

7.05

1.9

1.5

—

Other and unspecified disorders of adult personality and behaviour

4.23

7.05

1.5

1.4

—

Rash and other nonspecific skin eruption

132

803

1.66

7.04

1.9

1.5

—

Molar incisor enamel hypoplasia, with caries

3.16

7.02

11.0

2.6

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

3.17

7.01

1.2

—

Folate deficiency anaemia

3.83

7.00

1.3

1.2

—

Sequelae of inflammatory diseases of the central nervous system

8.02

6.96

2.9

1.0

—

Cerebral palsy

137

2.72

6.92

2.9

2.2

—

Viral pneumonia (known virus, not influenza)

210

2.34

6.85

1.7

2.1

—

Viral and other specified intestinal infections

301

2129

1.39

6.84

1.5

1.6

—

Other diseases of oesophagus

117

695

1.70

6.83

1.2

1.4

—

Secondary thrombocytopenia

3.26

6.82

1.6

1.2

—

Specific development disorders of scholastic skills

459

1.87

6.79

3.1

2.5

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

282

2.14

6.78

1.3

1.6

—

Adenomyosis (Endometriosis of uterus)

182

1204

1.52

6.73

1.4

1.3

—

Disturbances of smell and taste

237

2.23

6.70

1.3

1.5

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

442

1.89

6.70

1.6

1.4

—

Marginal zone B-cell lymphoma, including Hilmo

111

2.89

6.68

1.5

1.1

—

Drug-induced systemic lupus erythematosus

4.04

6.67

1.3

1.5

—

Metatarsalgia

129

792

1.65

6.65

1.3

1.5

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

306

2239

1.38

6.62

1.4

—

Other and unspecified disorders of white blood cells

306

2.07

6.56

3.3

1.5

—

Meralgia paraesthetica

266

2.15

6.56

1.2

1.5

—

Other and unspecified intracranial injuries

195

2.36

6.55

3.3

1.4

—

Sacroiliitis, not elsewhere classified

368

1.96

6.53

1.3

1.5

—

Late syphilis

3.23

6.53

1.6

1.1

—

Disorder of lipoprotein metabolism, unspecified

142

897

1.60

6.51

1.2

1.3

—

Eating disorders

165

1078

1.55

6.51

1.2

1.6

—

Other and unspecified coagulation defects

440

1.87

6.48

1.4

1.5

—

Persistent delusional disorders

103

601

1.74

6.46

1.3

1.4

—

Panniculitis affecting regions of neck and back

261

2.15

6.45

1.3

1.4

—

Mixed disorders of conduct and emotions, excluding more controls

166

2.47

6.42

1.3

2.2

—

Crushed, pushed or stepped on by crowd or human stampede

121

739

1.66

6.41

1.3

1.9

—

Bulimia nervosa (incl. atypical)

289

2.08

6.38

1.2

1.7

—

Shock, not elsewhere classified

6.13

6.37

1.1

1.2

—

Eating disorder

142

902

1.59

6.35

1.2

1.6

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

120

2.75

6.33

3.1

1.5

—

Selective deficiency of immunoglobulin G [IgG] subclasses

3.86

6.32

1.4

1.7

—

Tobacco use

473

1.83

6.31

1.3

1.4

—

Mental retardation, excluding more controls

260

2.12

6.30

2.2

3.0

—

Deficiency of other B group vitamins

138

2.60

6.27

1.3

1.5

—

Orchitis and epididymitis

110

659

1.69

6.25

1.5

—

Other peripheral vascular diseases

112

675

1.68

6.25

1.2

1.4

—

Early syphilis, including avohilmo

2.93

6.20

1.7

1.4

—

Arthropathies in other diseases classified elsewhere

259

2.13

6.18

1.8

1.4

—

Medical abortion

848

3806

1.21

6.16

1.4

—

Acute laryngitis and tracheitis

173

1139

1.51

6.15

2.1

1.5

—

Hereditary motor and sensory neuropathy

3.74

6.13

1.4

2.0

—

Other disorders of the genitourinary system

155

1015

1.54

6.12

1.3

—

Injury of unspecified body region

108

649

1.69

6.11

1.2

1.6

—

Unspecified event, undetermined intent

189

2.33

6.11

1.6

—

Early syphilis

3.04

6.10

1.8

1.4

—

Other sexually transmitted chlamydial diseases

107

642

1.69

6.10

1.6

1.5

—

Use of disulfiram, acamprosate or naltrexone

126

788

1.62

6.09

1.3

1.4

—

Carrier of infectious disease

183

2.35

6.09

1.5

1.6

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

336

1.97

6.08

1.6

—

Superficial injury of ankle and foot

189

1292

1.48

6.07

1.7

1.6

—

Other maltreatment syndromes

275

2.08

6.05

1.4

—

Type 1 diabetes

341

2570

1.33

6.05

1.5

—

Generalized skin eruption due to drugs and medicaments

310

2.01

5.99

1.8

—

Effects of other external causes

256

2.12

5.99

1.2

1.6

—

Other congenital malformations of skin

345

1.95

5.98

1.6

2.0

—

5.23

5.97

2.1

1.5

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

170

1142

1.50

5.97

1.4

1.3

—

Late syphilis, including avohilmo

107

2.79

5.93

1.5

1.2

—

Pedestrian injured in transport accident

587

1.71

5.90

1.2

1.4

—

Vascular dementia (multiple infarctions)

5.09

5.90

1.3

1.1

—

Hyperkalaemia

360

1.91

5.89

1.3

—

Overexertion and strenuous or repetitive movements

141

913

1.56

5.89

1.5

1.4

—

Disorder of the sleep-wake schedule

143

2.52

5.86

1.5

2.5

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cell count panel - Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS